Disease-modifying AD options “within a decade,” says Tetra CEO

This is an article about portfolio company, Tetra.

Scientists have shown that inflammatory disease in the body is associated with an increased risk of Alzheimer’s

View source version on thepharmaletter.com: https://www.thepharmaletter.com/article/disease-modifying-ad-options-within-a-decade-says-tetra-ceo